The difference in effectiveness could be attributed to tirzepatides GIP agonism and its more robust ability to promote weight loss
M.MirzabekovJ
In the past decade, CVOTs with GLP-1RAs have been conducted with at least seven agents including liraglutide, lixisenatide, exenatide, semaglutide, dulaglutide, albiglutide and oral semaglutide (Table 2)
ClmentFVidamentMGuerinB
Its approach combines: Psychology-based daily lessons and mindset tools grounded in behavioral science Coaching and accountability support Food, weight, and habit tracking in a single app Access to licensed clinicians through the Noom Med program Multiple medical pathways, including full-dose GLP-1s, microdose GLP-1s, and oral weight-loss medications Ongoing guidance for side-effect management, appetite changes, and long-term habit maintenance Within Noom Med, prescription optionsincluding injectables, oral medications, and microdose alternativesare integrated directly into the behavior-change program
We understand that every patient is unique, and we offer personalized treatment plans designed to address individual needs